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mP1M2 = 1040 mg mP1N    = 988 mg mP1P    = 780 mg mP1P    = 544 mg mP1C   = 463 mg 
RP1sep  = 0.95 RP1mf   = 0.79 RP1uf   = 0.70 RP1pur  = 0.85 
RP1int   =  0.45 
cP1M2   =     80 mgl
-1 cP1N      =   80 mgl
-1 cP1P      =   60 mgl
-1 cP1P      = 320 mgl
-1 cP1C     = 27.1 gl
-1 
PP1sec = 0.21 PP1uf = 0.21 PP1pur = 0.98 
Fully automated integrated production of Malaria vaccine D1M1H 
PP1int   =  0.98 
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Time course of six circular reproduced cell breeding cultivations 
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Spectroscopic NIR-investigation in production cycles reproducibility  
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• transform process data matrix X   
   into score matrix T  
   and loading matrix P 
• summarize m (22) informations  
   in a few variables r (2 or 3) only  
1st task: Autoscaling of Matrix D into X for principal component analysis 
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2nd task: Principal Component Analysis of autoscaled Data Matrix X   
• transformed m process data xj 
   into r (3) time dependent scores tl  
   (principle components  pcl )      
   with m . r loadings pjl    
    
    
Copyright Prof. Dr.-Ing. R. Luttmann 
Golden Batch tunnels with three sigma limits for process evaluation 
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Batch level score scatter plot (pc2 vs pc1) for different campaigns XXic1y 
 Hotellings T2 ellipse   
Are these models QbD-compliant? 
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Evaluation of optimization potential in secretion productivity PRD of D1   

 

          
         
k k P1Mkn Lkn Z Z/X XLkn P1Mk0 Lk0 Z Z/X XLk0
n
1
P1Mkj Skj Z Z/X XLkj Z kn k0 Lkn
j 1
y PRD c V (ρ α c ) c V (ρ α c )
c V (ρ α c ) (ρ (t t ) V )
Volumetric  secretion productivity PRD –  process evaluation performance criterion 
0.93 mg(lh)-1 
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Define Critical (Process) Quality Attribute: Product secretion productivity 
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k k P1Mkn Lkn Z Z/X XLkn P1Mk0 Lk0 Z Z/X XLk0
n
1
P1Mkj Skj Z Z/X XLkj Z kn k0 Lkn
j 1
y PRD c V (ρ α c ) c V (ρ α c )
c V (ρ α c ) (ρ (t t ) V )
 4.43 mg(lh)-1 
0.93 mg(lh)-1 
PRD 
Volumetric  secretion productivity PRD –  process evaluation performance criterion 
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Multi-bioreactor DoE-plant: BIOSTAT Bplus with a BIOSTAT Qplus 6  
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Optimal Critical Process Parameters in Malaria vaccine productions 
JLopt    =  25.8 °C  
pHopt   =  5.55  
cS2Mopt =  1.0  gl
-1  
D1: PRDmax = 0.019 AUsh
-1    
JLopt    = 24.7 °C  
pHopt   = 6.2 
cS2Mopt = 1.0 gl
-1  
D2M2D3H: PRDmax = 1.3 mg(lh)
-1    
JLopt    =  22.0 °C  
pHopt   =  5.55 
cS2Mopt = 1.0 gl
-1  
D1M1H: PRDmax = 9.0 mg(lh)
-1    
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Characterisation of an ellipsoid shape 
 DPMO: 104 
99 % success 
Control Space 
product: D1  
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Final evaluation of a new production with „optimal“ settings for XMV 
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On-line evaluation of MVDA models with SIPAT® and SIMCA® Q 
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On-line monitoring of Golden Batch variables in both sub-processes 
Is it possible to look into the future of process behaviour? 
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Process prediction and model predictive control with SIMCA®online 
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 cell breeding – product: D1M1H  
  
Quality control: BOBYQA – Bound Optimization BY Quadratic Approximation 
 BOBYQA – Minimize the quadratic deviation from an optimal process behaviour J 
2 2 2 2 2
XMV MVgb MV Y SP pred DModX T2J (X X ) (Y Y ) (DModX) (T )             
MVX
min J 
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 MPMC – Model Predictive Multivariate Control with the control model  
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